ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Chandan Healthcare Investor Presentation: Key Takeaways

Chandan Healthcare reported strong Q1 FY27 results with 19.62% YoY revenue growth and 42.27% EBITDA growth, driven by expansion into 15 states and diversified B2C, B2B, and B2G segments.

Highlights
Revenue growth19.62% YoY growth in Q1 FY27.
MarginsEBITDA margin at 25.5% (calc); PAT margin at 9.1% (calc).
Demand visibilityStrong; 3.19 million tests performed in Q1 alone.
Management confidenceHigh; citing strategic refinement and rapid network scaling.

Growth

Q1 FY27 revenue reached ₹82.26 Cr (up 19.62% YoY) and PAT hit ₹7.50 Cr (up 29.51% YoY).

Outlook

Targeting 1,000+ franchises by FY27; launching 2 PET-CT centres and Genome Lab; expanding pan-India network via CMC model.

Risks

Realignment through pharmacy business exit; competitive landscape in Tier 2/3 markets; high reliance on North India.

Source

Investor Presentation filed with NSE, NSE: CHANDAN. Summary written with AI assistance from the document.

Read the document ↗

Chandan Healthcare Ltd: key numbers

Share price
₹238.00
Market cap
₹611.7 Cr
Revenue (annual)
₹276.4 Cr
Net profit (annual)
₹27.06 Cr
P/E (TTM)
22.6×Sector 54.5×
Promoter holding
47.20%-2.41% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Chandan Healthcare Ltd

All →